Millions of Ohioans don't know they're inhaling air poisoned by radon, a gas estimated to lurk beneath about 50% of Ohio ...
With a phase 3 win for a combination of its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) ...
Dr. Charles M. Rudin highlighted new small cell lung cancer therapies, including T cell engagers, antibody-drug conjugates, ...
Patients with type 2 diabetes who use GLP-1 receptor agonists have a significantly lower risk for lung cancer than those who ...
Patients with lung cancer who smoke both tobacco and cannabis have a higher incidence of aggressive tumor types and emphysema.
Kelun Biotech's sac-TMT plus Merck's Keytruda shows significant progress in late-stage lung cancer trial. Read more here.
Jarryd Nurden was diagnosed with primary malignant neuroendocrine neoplasm of the lung, a rare form of lung cancer, in ...
One person's side effect could be another person's treatment if we expand our perspective on small molecule drug targets, according to a new study published November 5, 2025, in npj Precision Oncology ...
Theatre actor Jarryd Nurden has made a return to the West End stage just six months after undergoing surgery to remove half ...
The FDA has granted full approval to tarlatamab-dlle (Imdelltra) for the treatment of adult patients with extensive stage ...
Explore how DeepTarget can change perspectives on drug repurposing by broadening the view of small molecule targets.
"...she goes don’t bite me, and I goes no i ain’t going to bite you - I don’t have my dentures. I’ll gum you," said patient.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback